US 9572809
Combination therapy to treat Mycobacterium diseases
granted A61KA61K31/132A61K31/34
Quick answer
US patent 9572809 (Combination therapy to treat Mycobacterium diseases) held by SPERO TRINEM, INC. expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SPERO TRINEM, INC.
- Grant date
- Tue Feb 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/132, A61K31/34, A61K31/4164, A61K31/4168